IBMEC

Gamida Cell Appoints Terry Coelho as CFO

Retrieved on: 
Monday, May 22, 2023
Biotechnology, Pharmaceutical, Health, Stem Cells, Bachelor, Therapy, American University School of International Service, Diversey, Mars, DC, First wave, Sealed Air, MBA, Cell, AstraZeneca, Graduate School of Economics and International Relations, Novartis, Boxed warning, Mars, Incorporated, Atmosphere of Earth, Patient, IBMEC, CFO, Collection, Bone marrow, Regulation of tobacco by the U.S. Food and Drug Administration, Hematopoietic stem cell transplantation, Food, Pharmaceutical industry, Management, Economics

Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the appointment of Terry Coelho as Chief Financial Officer effective immediately.

Key Points: 
  • Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the appointment of Terry Coelho as Chief Financial Officer effective immediately.
  • Shai Lankry, who has served as the company’s CFO for the past five years, is stepping down as CFO today and will leave the company June 2.
  • “Terry has tremendous experience as CFO of commercial-stage biopharmaceutical companies.
  • “Omisirge has great commercial potential and the opportunity to fill a critical need for patients in need of stem cell transplant,” said Ms. Coelho.

HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors

Retrieved on: 
Monday, March 13, 2023
Arenavirus, University, First wave, Infection, Oncology, Diversey, Instituto Brasileiro de Economia, Mars, Incorporated, Compensated emancipation, University of North Carolina at Charlotte, Mars, Mercado, American University, Novartis, IBMEC, Management

NEW YORK and VIENNA, March 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced today that Terry Coelho will join its Board of Directors, Audit Committee and Compensation Committee, effective April 3, 2023.

Key Points: 
  • NEW YORK and VIENNA, March 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced today that Terry Coelho will join its Board of Directors, Audit Committee and Compensation Committee, effective April 3, 2023.
  • “Terry has worked with companies large and small and navigated fast-paced, complex business environments, including in the pharmaceutical sector.
  • She began her career at Mars, Inc.
    Ms. Coelho is a Member of the Board of Directors at First Wave BioPharma (NASDAQ: FWBI).
  • “It’s an exciting time to join HOOKIPA, with its strong pipeline in oncology and infectious diseases, as well as its strategic collaborations with premier players in the pharmaceutical sector,” said Terry Coelho.

MARS INCORPORATED APPOINTS NEW EQUITY, INCLUSION & DIVERSITY LEAD FOR NORTH AMERICA

Retrieved on: 
Tuesday, February 14, 2023
Organization, Life, Mars, Incorporated, Woman, Inclusion, Institute of Business Administration and Management, Associate, Emerging market, Kraft Foods, EI, Diversity, Shell, Workforce, BEN, Chief diversity officer, International Coaching Federation, Region, Culture, GSK plc, Food, Business administration, BG Group, Knowledge, Growth, Mercedes-Benz, Communication, Environment, Lenovo, IBMEC, Nursing, Management, Equity, Mars, Flavia

In her new role, Moreira will lead Equity, Inclusion & Diversity across all Mars North American businesses.

Key Points: 
  • In her new role, Moreira will lead Equity, Inclusion & Diversity across all Mars North American businesses.
  • "At Mars, we strive to ensure all Associates feel encouraged to be themselves and supported to reach their full potential," said Ibtehal Fathy, Global Inclusion & Diversity Officer.
  • Flavia brings a wealth of knowledge and unmatched success as a diversity and inclusion leader and we are thrilled to have her on our team."
  • The company continues track its progress against its goal as measured by the Mars Associate Survey, which also serves as its internal inclusion barometer.

Vitru Announces New Members of its Board of Directors

Retrieved on: 
Thursday, November 17, 2022
Kellogg School, Anima, Nature, Economics, McKinsey & Company, MBA, SVKM's NMIMS, Education, Executive Committee, S-1 Executive Committee, Investment, City of London Finance Committee, Committee on Finance, Cidinho and Doca, IBMEC, Management, Northwestern University, Vitrue, Inc.

FLORIANPOLIS, Brazil, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Vitru Limited (Vitru) announces that Mr. Daniel Arthur Borghi and Mr. Felipe Samuel Argalji have been appointed as directors of Vitru.

Key Points: 
  • FLORIANPOLIS, Brazil, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Vitru Limited (Vitru) announces that Mr. Daniel Arthur Borghi and Mr. Felipe Samuel Argalji have been appointed as directors of Vitru.
  • Other than as described in this press release, the composition of Vitrus board of directors remains the same.
  • He was a member of the board of directors of Afya Limited.
  • He was a member of the Finance Committee of Abril Educao, a member of the board of directors at Anima Educao and Afya Limited.

Avolon Announces Leadership Appointments

Retrieved on: 
Wednesday, October 5, 2022
Professional Services, Air, Transport, Finance, Aircraft, SLE, GE Aviation, CFO, NYSE, Orix, Regulation and licensure in engineering, COO, Capital market, Shenzhen Stock Exchange, Engineering, Massachusetts Institute of Technology, MBA, Research, CIT Group, New York Stock Exchange, Institute, University, Exco, IX, IBMEC, Marketing, Industry, LATAM, Trinity College Dublin, CEO, Aviation, CRO, Physics, Head, ISTAT, TSE, Policy, TAM, Trinity College, Portfolio management, Management, Risk management, Airline, Avolon, Technology, Science

Avolon, the international aircraft leasing company, announces appointments to the roles of Chief Financial Officer (CFO), Chief Operating Officer (COO), and Chief Risk Officer (CRO).

Key Points: 
  • Avolon, the international aircraft leasing company, announces appointments to the roles of Chief Financial Officer (CFO), Chief Operating Officer (COO), and Chief Risk Officer (CRO).
  • Andy Cronin, Avolon CEO, commented: Todays appointments further strengthen our leadership team and position us as an industry leader.
  • Jim joined Avolon in 2017 as a member of the OEM Team and was most recently Avolons Head of Portfolio Management.
  • Avolon is a global leader in aircraft leasing with an owned, managed and committed fleet, as of 30 June 2022 of 851 aircraft.

JBS hires new sustainability officer in Brazil

Retrieved on: 
Thursday, May 5, 2022
Zero, United Kingdom, Food safety, Food industry, National Wildlife Federation, Table, University, Supply chain, Collagen, Bauer, Company, Veterinary medicine, Palm oil, Pilgrim, Corporate Affairs, IBMEC, Biophysical environment, World, Private sector, ESALQ, Poultry, Intention, Berkeley, JBS, Solution, Recycling, Technology, Corporate sustainability, USP, Beef, WWF, Livestock

SÃO PAULO, May 5, 2022 /PRNewswire/ -- Having worked for the World Wildlife Fund (WWF) in Washington DC as Senior Director for the Beef and Leather Supply Chain, Maurício S. Bauer is taking up the position of Corporate Sustainability Officer of JBS Brazil with the aim of carrying out the sustainability strategy in Brazil in line with the Company's global targets.

Key Points: 
  • With extensive corporate experience in sustainability, Bauer takes up the position in May
    SO PAULO, May 5, 2022 /PRNewswire/ -- Having worked for the World Wildlife Fund (WWF) in Washington DC as Senior Director for the Beef and Leather Supply Chain, Maurcio S. Bauer is taking up the position of Corporate Sustainability Officer of JBS Brazil with the aim of carrying out the sustainability strategy in Brazil in line with the Company's global targets.
  • Maurcio has headed up projects in partnerships with the third sector, the private sector and universities, with the emphasis on strategies and solutions for the sustainable production of farm commodities, improvements to processes, innovation and technology.He will report to Marcela Rocha, Executive Officer for Corporate Affairs at JBS.
  • Maurcio is certified in Environmental Licensing from the University of California, Berkeley, and in Supply Chain and High-Performance Logistics Operations Management from the Brazilian Capital Markets Institute (IBMEC).He holds a degree in Veterinary Medicine from Paulista University and studied Agronomy at the University of So Paulo (ESALQ - USP).
  • This means that JBS will zero the net balance of its greenhouse gas emissions, reducing the intensity of the direct and indirect emissions and offsetting all residual emissions.JBS was the first global company in the protein sector to take on this commitment, with the intention of feeding people around the world in an increasingly sustainable manner.

JBS hires new sustainability officer in Brazil

Retrieved on: 
Thursday, May 5, 2022
Zero, United Kingdom, Food safety, Food industry, National Wildlife Federation, Table, University, Supply chain, Collagen, Bauer, Company, Veterinary medicine, Palm oil, Pilgrim, Corporate Affairs, IBMEC, Biophysical environment, World, Private sector, ESALQ, Poultry, Intention, Berkeley, JBS, Solution, Recycling, Technology, Corporate sustainability, USP, Beef, WWF, Livestock

SÃO PAULO, May 5, 2022 /PRNewswire/ -- Having worked for the World Wildlife Fund (WWF) in Washington DC as Senior Director for the Beef and Leather Supply Chain, Maurício S. Bauer is taking up the position of Corporate Sustainability Officer of JBS Brazil with the aim of carrying out the sustainability strategy in Brazil in line with the Company's global targets.

Key Points: 
  • With extensive corporate experience in sustainability, Bauer takes up the position in May
    SO PAULO, May 5, 2022 /PRNewswire/ -- Having worked for the World Wildlife Fund (WWF) in Washington DC as Senior Director for the Beef and Leather Supply Chain, Maurcio S. Bauer is taking up the position of Corporate Sustainability Officer of JBS Brazil with the aim of carrying out the sustainability strategy in Brazil in line with the Company's global targets.
  • Maurcio has headed up projects in partnerships with the third sector, the private sector and universities, with the emphasis on strategies and solutions for the sustainable production of farm commodities, improvements to processes, innovation and technology.He will report to Marcela Rocha, Executive Officer for Corporate Affairs at JBS.
  • Maurcio is certified in Environmental Licensing from the University of California, Berkeley, and in Supply Chain and High-Performance Logistics Operations Management from the Brazilian Capital Markets Institute (IBMEC).He holds a degree in Veterinary Medicine from Paulista University and studied Agronomy at the University of So Paulo (ESALQ - USP).
  • This means that JBS will zero the net balance of its greenhouse gas emissions, reducing the intensity of the direct and indirect emissions and offsetting all residual emissions.JBS was the first global company in the protein sector to take on this commitment, with the intention of feeding people around the world in an increasingly sustainable manner.

Afya Announces Changes to its Board of Directors

Retrieved on: 
Wednesday, April 20, 2022
Education, General Health, Health, Continuing, Board, Investment, Technology, UOL, IBMEC, Bertelsmann, School of Philosophy and Economic Science, UBS, Corporate finance, Esteves, Science, Director, Education, TMT, Management, Economics, SoftBank Group, Major airlines of the United States

Afya Limited, or Afya (Nasdaq: AFYA), announced that Mr. Paulo Passoni, a board member since May 2021, has submitted his resignation letter as a member of the Board of Directors.

Key Points: 
  • Afya Limited, or Afya (Nasdaq: AFYA), announced that Mr. Paulo Passoni, a board member since May 2021, has submitted his resignation letter as a member of the Board of Directors.
  • Mrs. Maria Tereza Azevedo was appointed as his replacement effective as of today.
  • Maria Tereza Azevedo joined Softbank LatAm fund in 2021 as Investment Director leading the Education industry.
  • Maria Tereza also serves as a board member of Descomplica and UOL EdTech.

CinCor Pharma Appoints Terry Coelho as Executive Vice President, Chief Financial Officer and Chief Business Development Officer

Retrieved on: 
Thursday, October 28, 2021
Primary aldosteronism, Death, CFO, Degenerative disease, American University School of International Service, Hypertension, CBDO, American Heart Association, Mars, Economics, Collection, American University, IBMEC, Patient, School, International studies, Leadership, Risk, Adult, American College of Cardiology, Aldosterone, Board, Growth, Stroke, Kidney disease, Health, American College, Acquisition, Population, GLOBE, Sealed Air, Novartis, EVP, Cardiology, Management, Pharmaceutical industry

CINCINNATI, Oct. 28, 2021 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (CinCor) today announced the appointment of Terry Coelho as Executive Vice President, Chief Financial Officer and Chief Business Development Officer (EVP, CFO and CBDO).

Key Points: 
  • CINCINNATI, Oct. 28, 2021 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (CinCor) today announced the appointment of Terry Coelho as Executive Vice President, Chief Financial Officer and Chief Business Development Officer (EVP, CFO and CBDO).
  • Terry gained broad financial and operational leadership experience at several high-profile and start-up companies, including in the biopharmaceutical sector, said Marc de Garidel, Chief Executive Officer of CinCor.
  • Our entire management team and the Board are very excited to welcome Terry to CinCor.
  • Prior to joining BioDelivery Services, Ms. Coelho served as the Chief Financial Officer of Balchem Corp., a specialty chemicals manufacturer for the human and animal health and nutrition markets.

AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

Retrieved on: 
Monday, August 16, 2021
NASDAQ, MBA, Graduate School of Economics and International Relations, U.S. Securities and Exchange Commission, Arbutus Biopharma, Novartis, Committee, Niclosamide, DC, Mars, Clinical trial, CEO, Achievement, IBMEC, Company, American University School of International Service, Bachelor, COVID-19, International Service for the Acquisition of Agri-biotech Applications, GLOBE, EPI, Exocrine pancreatic insufficiency, Nature, Security (finance), Patient, Board, Growth, Sealed Air, Executive, Board of directors, BCPC, Knowledge, Diarrhea, Cystic fibrosis, BOCA, International relations, Management, Pharmaceutical industry

BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AzurRx or the Company) ( NASDAQ: AZRX ), a company specializing in the development of targeted non-systemic, therapies forgastrointestinal (GI) diseases, today announced the appointment of Terry Coelho to its Board of Directors effective immediately.

Key Points: 
  • BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AzurRx or the Company) ( NASDAQ: AZRX ), a company specializing in the development of targeted non-systemic, therapies forgastrointestinal (GI) diseases, today announced the appointment of Terry Coelho to its Board of Directors effective immediately.
  • Terry brings to AzurRx unrivaled financial and operational experience, which will be critical to our growth and long-term success.
  • On behalf of the Board, I am pleased to welcome Terry to AzurRx and look forward to benefitting from her knowledge and expertise.
  • I am honored to be joining the Board of AzurRx BioPharma, said Ms. Coelho.